Multidisciplinary Research Training in Cardiovascular Disease

项目总结 人类基因组测序的成功和人类健康服务研究的进展 后基因组时代与成像技术的惊人进步相结合，提供了前所未有的 改变心血管疾病患者护理的机会。在过去的十年里，威尔·康奈尔医学公司 (WCM)在生物医学研究以及研究培训和基础设施方面进行了重大投资。 WCM请求支持4名临床和非临床博士后研究员在一个新的 心血管疾病多学科研究培训计划(MRTP)，由WCM提供资金 一个额外的培训时段。我们的目标是招聘基础扎实的优秀应聘者 科学和/或临床研究，并培训他们将他们的知识和技能应用于解决重要的 在心血管疾病患者的预防、诊断和治疗方面临床上未得到满足的需求。 MRTP实习生将获得为期3年的计划支持，在此期间，他们将遵循系统和严格的 博士后培训计划。MRTP将由来自WCM纪念馆的20位杰出的导师共同努力 斯隆·凯特琳癌症中心(MSKCC)和洛克菲勒大学(RU)，构成了一个密集的网络 合作研究人员，他们是与心血管生理学直接相关领域的国际领先者 和疾病。这些导师被组织成两个主题但相互关联的研究培训单元： 分子和细胞信号与心血管成像。这些培训单位将使发展 针对具体内容的教育规划，以及提高培训中的管理效率 程序。监督将由由该计划组成的研究培训执行委员会提供 主任和两名协理方案主任，他们也将担任培训股的负责人，以及3名 其他成员将就临床/流行病学研究提供具体指导，实现和 在培训计划和指导方面保持多样性。我们还集结了一支杰出的 内部和外部咨询委员会成员名册，其任务是评估该方案并提供 提出了提高其质量和效率的具体建议。MRTP的高度个性化培训 该计划将包括1)个人发展计划；2)严格的研究培训；3)实践经验 尖端方法；以及4)综合课程。学员将进一步受益于广泛的 WCM、MSKCC和RU的机构资源。根据人们对我们奖学金项目的兴趣程度， 我们预计将有大量高资质的临床和非临床候选人参加拟议的MRTP， 这将保持一个强大的多样性重点。通过其严谨、结构化和高度个性化的课程， 这一新的培训计划旨在培养心血管疾病研究的未来领导者，他们准备 将他们的发现转化为改善患者护理。

PROJECT SUMMARY The successful sequencing of the human genome and the evolution of human health services research in the post-genomic era combined with startling advances in imaging technology have offered unprecedented opportunities to transform patient care in cardiovascular diseases. Over the past decade, Weill Cornell Medicine (WCM) has made major investments in biomedical research, as well as research training and infrastructure. WCM requests support for the research training of 4 clinical and non-clinical postdoctoral fellows in a new multidisciplinary research training program (MRTP) in Cardiovascular Disease, with WCM providing funding for an additional training slot. The objective is to recruit outstanding candidates with solid foundations in basic science and/or clinical research and train them to apply their knowledge and skills towards addressing important clinically unmet needs in the prevention, diagnosis, and treatment of patients with cardiovascular diseases. MRTP trainees will receive program support for 3 years during which they will follow a structured and rigorous postdoctoral training program. The MRTP will be a joint effort of 20 eminent preceptors from WCM, Memorial Sloan Kettering Cancer Center (MSKCC) and the Rockefeller University (RU), which constitute a dense network of collaborative researchers, who are international leaders in fields directly relevant to cardiovascular physiology and disease. These preceptors have been organized into 2 themed, but interconnected units of research training: molecular and cell signaling and cardiovascular imaging. These training units will enable the development of content-specific educational programming, as well as increase the efficiency administration within the training program. Oversight will be provided by a Research Training Executive Committee consisting of the Program Director and two Associate Program Directors, who will also serve as leaders of the training units, as well as 3 additional members who will provide specific guidance on clinical/epidemiologic research, on achieving and maintaining diversity within the training program, and on mentoring. We have also assembled an outstanding roster of internal and external advisory board members with a mandate to evaluate the program and provide specific recommendations to improve both its quality and efficiency. The MRTP's highly personalized training program will include 1) individual development plans; 2) rigorous research training; 3) hands-on experience in cutting-edge methodologies; and 4) an integrated curriculum. Trainees will further benefit from the extensive institutional resources of WCM, MSKCC and RU. Based upon the levels of interest in our fellowship programs, we anticipate a substantial pool of highly qualified clinical and non-clinical candidates for the proposed MRTP, which will maintain a strong diversity focus. Through its rigorous, structured and highly personalized curriculum, this new training program seeks to train future leaders in cardiovascular disease research who are prepared to translate their findings towards improving patient care.